Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and February 2017

Showing 1 to 10 of 318
Title Reference number Published Last updated
Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation Reference number:TA429 TA00429 Published:January 2017 20170101 Last updated:January 2017 20170125
Sofosbuvir–velpatasvir for treating chronic hepatitis C Reference number:TA430 TA00430 Published:January 2017 20170101 Last updated:January 2017 20170125
Mepolizumab for treating severe refractory eosinophilic asthma Reference number:TA431 TA00431 Published:January 2017 20170101 Last updated:January 2017 20170125
Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib Reference number:TA427 TA00427 Published:January 2017 20170101 Last updated:January 2017 20170111
Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy Reference number:TA428 TA00428 Published:January 2017 20170101 Last updated:January 2017 20170111
Everolimus with exemestane for treating advanced breast cancer after endocrine therapy Reference number:TA421 TA00421 Published:December 2016 20161201 Last updated:December 2016 20161221
Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer Reference number:TA422 TA00422 Published:December 2016 20161201 Last updated:December 2016 20161221
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens Reference number:TA423 TA00423 Published:December 2016 20161201 Last updated:December 2016 20161221
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer Reference number:TA424 TA00424 Published:December 2016 20161201 Last updated:December 2016 20161221
Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia Reference number:TA425 TA00425 Published:December 2016 20161201 Last updated:December 2016 20161221